Some comparative aspects of rifampicin and isoniazid-Reference-Cited by-同舟云学术

Some comparative aspects of rifampicin and isoniazid

Published:1968-12 Issue:4 Volume:49 Page:367-376
ISSN:0041-3879
Container-title:Tubercle
language:en
Short-container-title:Tubercle

Author:

Canetti G.,le Lirzin M.,Porven G.,Rist N.,Grumbach F.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference23 articles.

1. Teneur des souches sauvages de Mycobacterium tuberculosis en variants résistants à l'isoniazide et en variants résistants à la streptomycine sur milieu de Löwenstein-Jensen;Canetti;Annls Inst. Pasteur,1961

2. Une classification des drogues antituberculcuses selon les taux sanguins chez l'homme;Canetti;Revue Tuberc. Pneumol,1969

3. Remarques sur la résistance in vitro des staphylocoques à la rifamycine SV;Chabbert;Chemotherapia, Basel,1963

4. Modifications pratiques concernant le dosage des antibiotiques en clinique;Chabbert;Revue fr. Et. Clin. Biol.,1957

5. The susceptibility of mycobacteria to rifamide and rifampicin;Clark;Tubercle. Lond.,1967

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The basis of tuberculosis treatment: fundamental concepts before treating a patient;The Challenge of Tuberculosis in the 21st Century;2023-09-01

2. Rationale for Anti-Tuberculosis Chemotherapy;Essential Tuberculosis;2021

3. Insight about cell wall remodulation triggered by rifampicin in Mycobacterium tuberculosis;Tuberculosis;2020-01

4. Heteroresistance: A Harbinger of Future Resistance;Antimicrobial Resistance in the 21st Century;2018

5. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement;The International Journal of Tuberculosis and Lung Disease;2016-01-01